Latest research

  1. Article

    Centanafadine: First Approval

    • Connie Kang
    in Drugs

    Centanafadine (SIMTRIYO®) is a first-in-class, sustained-release norepinephrine, dopamine and serotonin reuptake inhibitor and central nervous system stimulant developed by Otsuka Pharmaceutical for the treatment of attention-deficit hyperactivity...

    24 October 2026
View all research